CSL (MEX:CSL N) Short-Term Debt : MXN15,535 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CSL Short-Term Debt?

CSL's Short-Term Debt for the quarter that ended in Jun. 2024 was MXN15,535 Mil.

CSL's quarterly Short-Term Debt increased from Jun. 2023 (MXN16,527 Mil) to Dec. 2023 (MXN24,103 Mil) but then declined from Dec. 2023 (MXN24,103 Mil) to Jun. 2024 (MXN15,535 Mil).

CSL's annual Short-Term Debt declined from Jun. 2022 (MXN88,932 Mil) to Jun. 2023 (MXN16,527 Mil) and declined from Jun. 2023 (MXN16,527 Mil) to Jun. 2024 (MXN15,535 Mil).

CSL Short-Term Debt Historical Data

The historical data trend for CSL's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Short-Term Debt Chart

CSL Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Short-Term Debt

Get a 7-Day Free Trial

2,862.18

7,882.78

88,931.62

16,526.72

15,535.45

CSL Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Short-Term Debt	Get a 7-Day Free Trial															88,931.62	23,714.93	16,526.72	24,103.43	15,535.45

CSL Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

CSL Short-Term Debt Related Terms

Thank you for viewing the detailed overview of CSL's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CSL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (MEX:CSL N) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

CSLLY:USA CMXHF:USA CSJ:Germany CSJ:Germany CSJ:Germany CSL:Australia

Address

655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website

https://www.csl.com

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.

CSL Headlines

No Headlines